Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Seddik

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Gastroenterologie Clinique Et Biologique|November 11, 2008
[Small-bowel gangrene revealing a Yersinia pseudotuberculosis infection]H Seddik, R Ahtil, H En-Nouali, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort ApproachAhmed H Seddik, Claudio Schiener, Dennis A Ostwald, et al.
Cephalalgia : an International Journal of Headache|August 9, 2020
The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in GermanyAhmed H Seddik, Jennifer C Branner, Dennis A Ostwald, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|March 31, 2009
[Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case]A El Khattabi, H Seddik, J Fatihi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic ReviewAhmed H Seddik, Jeroen Paulissen, Ramesh Marapin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 24, 2023
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in FinlandJeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Gastroenterologie Clinique Et Biologique|November 11, 2008
[Small-bowel gangrene revealing a Yersinia pseudotuberculosis infection]H Seddik, R Ahtil, H En-Nouali, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort ApproachAhmed H Seddik, Claudio Schiener, Dennis A Ostwald, et al.
Cephalalgia : an International Journal of Headache|August 9, 2020
The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in GermanyAhmed H Seddik, Jennifer C Branner, Dennis A Ostwald, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|March 31, 2009
[Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case]A El Khattabi, H Seddik, J Fatihi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic ReviewAhmed H Seddik, Jeroen Paulissen, Ramesh Marapin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 24, 2023
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in FinlandJeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton, et al.
Pageof 2